Connect with us

Science

Synlogic Publishes Papers in Nature Journals Demonstrating Proof-of-Mechanism and Potential of Synthetic Biotic Platform for the Treatment of Phenylketonuria (PKU) – StreetInsider.com

CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative…

Published

on

Article feature image

CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today the publication of two papers in the journals Nature Metabolism…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending